Stay updated on Empagliflozin Effect on Tissue Sodium in Heart Failure Clinical Trial
Sign up to get notified when there's something new on the Empagliflozin Effect on Tissue Sodium in Heart Failure Clinical Trial page.

Latest updates to the Empagliflozin Effect on Tissue Sodium in Heart Failure Clinical Trial page
- Check7 days agoChange DetectedThe page's revision line was updated from 'Revision: v3.6.2' to 'Revision: v3.6.3', reflecting an updated page version.SummaryDifference0.1%

- Check14 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing the previous Revision: v3.6.0, indicating a small platform update to the study details page.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the recruitment status to No longer looking for participants. It also standardizes the label from 'Intervention / Treatment' to 'Intervention/Treatment' and updates the revision version from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check35 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, representing a minor page version update for the ClinicalTrials.gov record.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page revision label was updated to v3.5.4, replacing the previous v3.5.3. This reflects a minor update to the page without changes to the core study content.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page revision label was updated from v3.5.2 to v3.5.3, reflecting an internal/website version change rather than a change to the clinical study record.SummaryDifference0.1%

Stay in the know with updates to Empagliflozin Effect on Tissue Sodium in Heart Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Empagliflozin Effect on Tissue Sodium in Heart Failure Clinical Trial page.